MarketLens
Sign Up

Why is AbbVie Investing $380 Million in US Manufacturing

6 months ago
SHARE THIS ON:

Why is AbbVie Investing $380 Million in US Manufacturing

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support

AbbVie awarded 34 students the 2026 Immunology Scholarship, marking the program's 10th year since 2016. The renewable award supports up to four years for students with inflammatory conditions, reinfor...
Stock News1 months ago

Lilly, Resilience to invest $750 million in US drug manufacturing expansion

Eli Lilly and Resilience will invest $750 million to expand US pharmaceutical manufacturing capacity, strengthening the domestic medicine supply chain, Resilience announced Thursday.
Stock News1 months ago

3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st

AbbVie enters its July 31 Q2 earnings report with a 2.62% dividend yield, raised earnings guidance, and two blockbuster drugs growing above 20%.
Stock News1 months ago

WST Completes SmartDose Sale to AbbVie to Focus on Core Growth

West Pharmaceutical completed the SmartDose 3.5mL sale to AbbVie, sharpening its focus on higher-growth on-body drug delivery technologies.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

This AI Energy Stock Is Up Nearly 2,000% in the Last Two Years. Could It Be Nvidia's Next Big Investment?

Stock News2 hours ago

Microsoft's stock seals its longest winning streak of the year as AI software fears fade

Stock News2 hours ago

Stock Market Today, Aug. 28: Marvell Slides 10% on Softer Fiscal 2028 Guidance and Google Deal Timing

Stock News2 hours ago

This AI Fund Is Crushing QQQ, and Nvidia Is Barely 2% of It

Stock News3 hours ago

4 Space Catalysts — and Where Capital Flows Next